Skip to menu Skip to content Skip to footer

2015

Journal Article

Facing the challenges of new melanoma-targeted therapies: treatment of severe fevers associated with dabrafenib/trametinib combination therapy

Lindsay, Julian N. and Barras, Michael (2015). Facing the challenges of new melanoma-targeted therapies: treatment of severe fevers associated with dabrafenib/trametinib combination therapy. Journal of Oncology Pharmacy Practice, 21 (4), 293-295. doi: 10.1177/1078155214527859

Facing the challenges of new melanoma-targeted therapies: treatment of severe fevers associated with dabrafenib/trametinib combination therapy

2015

Journal Article

Comparison of 2 weight-based heparin dosing nomograms in neurology and vascular surgical patients

Marotti, Sally B., Barras, Michael and Kirkpatrick, Carl (2015). Comparison of 2 weight-based heparin dosing nomograms in neurology and vascular surgical patients. Therapeutic Drug Monitoring, 37 (1), 33-39. doi: 10.1097/FTD.0000000000000099

Comparison of 2 weight-based heparin dosing nomograms in neurology and vascular surgical patients

2015

Book Chapter

Peri-procedural anticoagulation

Barras, Michael (2015). Peri-procedural anticoagulation. Anticoagulation management: a guide for pharmacists . (pp. 179-199) edited by Anne Rose. Cham, Switzerland: Springer International Publishing. doi: 10.1007/978-3-319-22602-6_8

Peri-procedural anticoagulation

2015

Journal Article

Engaging pharmacists in clinical research

Barras, Michael (2015). Engaging pharmacists in clinical research. Australian Journal of Pharmacy, 96 (1139)

Engaging pharmacists in clinical research

2014

Journal Article

Improving Care Transitions in Individuals Frequently Admitted to the Hospital

Mudge, Alison M., Barras, Michael, Adsett, Julie, Mullins, Robert W., Lloyd, Sophie and Kasper, Karen (2014). Improving Care Transitions in Individuals Frequently Admitted to the Hospital. Journal of the American Geriatrics Society, 62 (10), 1994-1996. doi: 10.1111/jgs.13033

Improving Care Transitions in Individuals Frequently Admitted to the Hospital

2014

Journal Article

The development and evaluation of an oncological palliative care deprescribing guideline: the 'OncPal deprescribing guideline'

Lindsay, Julian, Dooley, Michael, Martin, Jennifer, Fay, Michael, Kearney, Alison, Khatun, Mohsina and Barras, Michael (2014). The development and evaluation of an oncological palliative care deprescribing guideline: the 'OncPal deprescribing guideline'. Supportive Care in Cancer, 23 (1), 71-78. doi: 10.1007/s00520-014-2322-0

The development and evaluation of an oncological palliative care deprescribing guideline: the 'OncPal deprescribing guideline'

2014

Journal Article

Reducing potentially inappropriate medications in palliative cancer patients: evidence to support deprescribing approaches

Lindsay, Julian, Dooley, Michael, Martin, Jennifer, Fay, Michael, Kearney, Alison and Barras, Michael (2014). Reducing potentially inappropriate medications in palliative cancer patients: evidence to support deprescribing approaches. Supportive Care in Cancer, 22 (4), 1113-1119. doi: 10.1007/s00520-013-2098-7

Reducing potentially inappropriate medications in palliative cancer patients: evidence to support deprescribing approaches

2014

Journal Article

Reporting a population pharmacokinetic-pharmacodynamic study: a journal's perspective

Jamsen, Kris M., McLeay, Sarah C., Barras, Michael A. and Green, Bruce (2014). Reporting a population pharmacokinetic-pharmacodynamic study: a journal's perspective. Clinical Pharmacokinetics, 53 (2), 111-122. doi: 10.1007/s40262-013-0114-1

Reporting a population pharmacokinetic-pharmacodynamic study: a journal's perspective

2013

Journal Article

Reducing the risk of harm from intravenous potassium: a multi-factorial approach in the haematology setting

Barras, Michael, Moore, Diana, Pocock, Daniel, Sweedman, Myles, Wilkinson, Cathy, Taylor, Kerry and Morton, James (2013). Reducing the risk of harm from intravenous potassium: a multi-factorial approach in the haematology setting. Journal of Oncology Pharmacy Practice, OnlineFirst (5), 1-10. doi: 10.1177/1078155213504443

Reducing the risk of harm from intravenous potassium: a multi-factorial approach in the haematology setting

2013

Journal Article

Abnormal laboratory results: anti-Xa assays

Barras, Michael (2013). Abnormal laboratory results: anti-Xa assays. Australian Prescriber, 36 (3), 98-101. doi: 10.18773/austprescr.2013.036

Abnormal laboratory results: anti-Xa assays

2013

Conference Publication

Implementation and Evaluation of an Interprofessional Curriculum

Cottrell, Neil, Waller, Susan, Barras, Michael, Burston, Adam, Dickie, Robyn, Groves, Michele, Kendall, Bradley and Rylands, Linda (2013). Implementation and Evaluation of an Interprofessional Curriculum. Collaborating Across Borders III (CAB III) Interprofessional Collaboration: From Concept to Preparation to Practice, Tucson, AZ, United States, 19-21 November 2011. London, United Kingdom: Informa Healthcare. doi: 10.3109/13561820.2013.761518

Implementation and Evaluation of an Interprofessional Curriculum

2012

Journal Article

Medicinal mishap: Dabigatran - a new safe drug to replace an old poison?

Iedema, Joel, Barras, Michael, Sundac, Lana and Coombes, Ian (2012). Medicinal mishap: Dabigatran - a new safe drug to replace an old poison?. Australian Prescriber, 35 (2), 64-65. doi: 10.18773/austprescr.2012.029

Medicinal mishap: Dabigatran - a new safe drug to replace an old poison?

2012

Journal Article

Gentamicin monitoring practices in teaching hospitals – time to undertake the necessary randomised controlled trial

Martin, Jennifer, Barras, Michael, Yui, Nicholas Ah, Kirkpatrick, Carl, Kubler, Paul and Norris, Ross (2012). Gentamicin monitoring practices in teaching hospitals – time to undertake the necessary randomised controlled trial. Journal of Clinical Toxicology, 2 (8), 146.1-146.5. doi: 10.4172/2161-0495.1000146

Gentamicin monitoring practices in teaching hospitals – time to undertake the necessary randomised controlled trial

2012

Journal Article

Gentamicin use - more clinical outcome evidence needed

Martin, Jennifer, Norris, Ross and Barras, Michael (2012). Gentamicin use - more clinical outcome evidence needed. Journal of Clinical Toxicology, 2 (6), e110.1-e110.2. doi: 10.4172/2161-0495.1000e110

Gentamicin use - more clinical outcome evidence needed

2011

Journal Article

Recurrent readmissions in medical patients: A prospective study

Mudge, AM, Kasper, K, Clair, A, Redfern, H, Bell, JJ, Barras, MA, Dip, G and Pachana, NA (2011). Recurrent readmissions in medical patients: A prospective study. Journal of Hospital Medicine, 6 (2), 61-67. doi: 10.1002/jhm.811

Recurrent readmissions in medical patients: A prospective study

2011

Journal Article

Bayesian optimisation of tobramycin dosing in paediatric patients with cystic fibrosis

Barras, Michael, Alraman, Hana, Kirkpatrick, Carl M. J., Harris, Margaret, Dakin, Carolyn, Jess, Katrina, Pilbeam, Melissa and Norris, Ross L. G. (2011). Bayesian optimisation of tobramycin dosing in paediatric patients with cystic fibrosis. Journal of Pharmacy Practice and Research, 41 (3), 183-187. doi: 10.1002/j.2055-2335.2011.tb00857.x

Bayesian optimisation of tobramycin dosing in paediatric patients with cystic fibrosis

2011

Conference Publication

Comparison of one vs. two blood samples for determination of tobramycin AUC in children with cystic fibrosis

Norris, R. L. G., Barras, M., Alraman, H., Kirkpatrick, C., Dakin, C., Harris, M. and Jess, K. (2011). Comparison of one vs. two blood samples for determination of tobramycin AUC in children with cystic fibrosis. 12th International Congress of Therapeutic Drug Monitoring and Clinical Toxicology, Stuttgart, Germany, 2-6 October 2011. Philadelphia PA, United States: Lippincott Wiliams & Wilkins. doi: 10.1097/01.ftd.0000400651.94145.ba

Comparison of one vs. two blood samples for determination of tobramycin AUC in children with cystic fibrosis

2010

Journal Article

Current status of therapeutic drug monitoring in Australia and New Zealand: A need for improved assay evaluation, best practice guidelines, and professional development

Norris, Ross L., Martin, Jennifer H., Thompson, Erin, Ray, John E., Fullinfaw, Robert O., Joyce, David, Barras, Michael, Jones, Graham R. and Morris, Raymond G. (2010). Current status of therapeutic drug monitoring in Australia and New Zealand: A need for improved assay evaluation, best practice guidelines, and professional development. Therapeutic Drug Monitoring, 32 (5), 615-623. doi: 10.1097/FTD.0b013e3181ea3e8a

Current status of therapeutic drug monitoring in Australia and New Zealand: A need for improved assay evaluation, best practice guidelines, and professional development

2010

Journal Article

Individualized dosing of enoxaparin for subjects with renal impairment is superior to conventional dosing at achieving therapeutic concentrations

Barras, Michael A., Duffull, Stephen B., Atherton, John J. and Green, Bruce (2010). Individualized dosing of enoxaparin for subjects with renal impairment is superior to conventional dosing at achieving therapeutic concentrations. Therapeutic Drug Monitoring, 32 (4), 482-488. doi: 10.1097/FTD.0b013e3181e64846

Individualized dosing of enoxaparin for subjects with renal impairment is superior to conventional dosing at achieving therapeutic concentrations

2010

Journal Article

Current dosing of low-molecular-weight heparins does not reflect licensed product labels: An international survey

Barras, Michael A., Kirkpatrick, Carl M.J. and Green, Bruce (2010). Current dosing of low-molecular-weight heparins does not reflect licensed product labels: An international survey. British Journal of Clinical Pharmacology, 69 (5), 520-528. doi: 10.1111/j.1365-2125.2010.03626.x

Current dosing of low-molecular-weight heparins does not reflect licensed product labels: An international survey